Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Darapiseth, Sea"'
Autor:
Bertha Wojnarski, Chanthap Lon, Darapiseth Sea, Somethy Sok, Sabaithip Sriwichai, Soklyda Chann, Sohei Hom, Threechada Boonchan, Sokna Ly, Chandara Sok, Samon Nou, Pheaktra Oung, Nareth Kong, Vannak Pheap, Khengheang Thay, Vy Dao, Worachet Kuntawunginn, Mitra Feldman, Panita Gosi, Nillawan Buathong, Mali Ittiverakul, Nichapat Uthaimongkol, Rekol Huy, Michele Spring, Dysoley Lek, Philip Smith, Mark M Fukuda, Mariusz Wojnarski
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
BACKGROUND:Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable po
Externí odkaz:
https://doaj.org/article/ef08d2a9d03b4085b8f7f6c4f4c956af
Autor:
Soklyda Chann, Mariusz Wojnarski, Brian Vesely, Piyaporn Saingam, Prom Satharath, Nonlawat Boonyalai, Chaiyaporn Chaisatit, Paphavee Lertsethtakarn, Michele D. Spring, Somethy Sok, Zalak Shah, Panita Gosi, Huy Rekol, Matthew Adams, Biraj Shrestha, David L. Saunders, Molly Deutsch-Feldman, Andrew P. Morgan, Darapiseth Sea, Chantida Praditpol, Philip L. Smith, Shannon Takala-Harrison, Dysoley Lek, Chanthap Lon, Jessica T. Lin, Norman C. Waters, Stuart D. Tyner, Charlotte A. Lanteri, Suwanna Chaorattanakawee
Publikováno v:
J Infect Dis
Background Newly emerged mutations within the Plasmodium falciparum chloroquine resistance transporter (PfCRT) can confer piperaquine resistance in the absence of amplified plasmepsin II (pfpm2). In this study, we estimated the prevalence of co-circu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f137f945ef4e8683d305ca27f531537e
https://doi.org/10.1093/infdis/jiab055
https://doi.org/10.1093/infdis/jiab055
Autor:
Pattaraporn Vanachayangkul, Darapiseth Sea, Mariusz Wojnarski, Somethy Sok, Chanikarn Kodchakorn, Winita Ta-aksorn, Sohei Hom, Mali Ittiverakul, Worachet Kuntawunginn, Montri Arsanok, Nillawan Buathong, Thay Kheang Heng, Kong Nareth, Samon Nou, Sok Chandara, Sokna Ly, Pheaktra Oung, Brian Vesely, Jason Bennett, Gregory Reichard, Brandon Pybus, Charlotte Lanteri, David Saunders, Mark Fukuda, Philip Smith, Lek Dysoley, Huy Rekol, Norman C. Waters, Michele Spring
Publikováno v:
Antimicrob Agents Chemother
The active metabolites of primaquine, in particular 5-hydroxyprimaquine, likely responsible for the clearance of dormant hypnozoites, are produced through the hepatic CYP450 2D6 (CYP2D6) enzymatic pathway. With the inherent instability of 5-hydroxypr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c7c4fcc52d519f4e5c02be656dbde4
https://pubmed.ncbi.nlm.nih.gov/34978892
https://pubmed.ncbi.nlm.nih.gov/34978892
Autor:
Chanthap Lon, Jessica E Manning, Pattaraporn Vanachayangkul, Mary So, Darapiseth Sea, Youry Se, Panita Gosi, Charlotte Lanteri, Suwanna Chaorattanakawee, Sabaithip Sriwichai, Soklyda Chann, Worachet Kuntawunginn, Nillawan Buathong, Samon Nou, Douglas S Walsh, Stuart D Tyner, Jonathan J Juliano, Jessica Lin, Michele Spring, Delia Bethell, Jaranit Kaewkungwal, Douglas Tang, Char Meng Chuor, Prom Satharath, David Saunders
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e93138 (2014)
Emerging antimalarial drug resistance in mobile populations remains a significant public health concern. We compared two regimens of dihydroartemisinin-piperaquine in military and civilians on the Thai-Cambodian border to evaluate national treatment
Externí odkaz:
https://doaj.org/article/3a4397fd82884b5f87e273d711c42f01
Autor:
Michele D, Spring, Chanthap, Lon, Somethy, Sok, Darapiseth, Sea, Mariusz, Wojnarski, Soklyda, Chann, Worachet, Kuntawunginn, Thay, Kheang Heng, Samon, Nou, Montri, Arsanok, Sabaithip, Sriwichai, Pattaraporn, Vanachayangkul, Jessica T, Lin, Jessica E, Manning, Krisada, Jongsakul, Sathit, Pichyangkul, Prom, Satharath, Philip L, Smith, Lek, Dysoley, David L, Saunders, Norman C, Waters
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Clinical failure of primaquine (PQ) has been demonstrated in people with CYP450 2D6 genetic polymorphisms that result in reduced or no enzyme activity. The distribution of CYP2D6 genotypes and predicted phenotypes in the Cambodian population is not w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab5a0c84387197970450b6df573230cb
https://pubmed.ncbi.nlm.nih.gov/32394887
https://pubmed.ncbi.nlm.nih.gov/32394887
Autor:
Threechada Boonchan, Panita Gosi, Worachet Kuntawunginn, Soklyda Chann, Samon Nou, Rekol Huy, Dysoley Lek, Sabaithip Sriwichai, Nillawan Buathong, Darapiseth Sea, Vy Dao, Somethy Sok, Bertha Wojnarski, Nichapat Uthaimongkol, Mark M. Fukuda, Chanthap Lon, Pheaktra Oung, Michele D. Spring, Nareth Kong, Khengheang Thay, Sohei Hom, Sokna Ly, Mariusz Wojnarski, Mali Ittiverakul, Mitra Feldman, Philip A. Smith, Vannak Pheap, Chandara Sok
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
Background Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82c8c823ab924c57b43918dbfcc87e3
https://pubmed.ncbi.nlm.nih.gov/32004348
https://pubmed.ncbi.nlm.nih.gov/32004348
Autor:
Nillawan Buathong, Jessica T. Lin, Darapiseth Sea, Philip A. Smith, Shannon Takala-Harrison, Mariusz Wojnarski, Chanthap Lon, Khengheng Thay, Mark M. Fukuda, Nou Samon, Panita Gosi, Michele D. Spring, Rekol Huy, Suwanna Chaorattanakawee, Jaymin C. Patel, David L. Saunders, Soklyda Chann, Lauren Levitz
Gametocytes are the malaria parasite stages responsible for transmission from humans to mosquitoes. Gametocytemia often follows drug treatment, especially as therapies start to fail. We examined Plasmodium falciparum gametocyte carriage and drug resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e74a19eae2b6d3da5b85ddb7c3f077b
https://europepmc.org/articles/PMC6221238/
https://europepmc.org/articles/PMC6221238/
Autor:
Piyaporn Saingam, Stuart D. Tyner, Christopher V. Plowe, Nillawan Buathong, Shannon Takala-Harrison, Chanthap Lon, David L. Saunders, Jessica T. Lin, Panita Gosi, Kritsanai Yingyuen, Nareth Kong, Youry Se, Satharath Prom, Suwanna Chaorattanakawee, Charlotte A. Lanteri, Worachet Kuntawunginn, Christopher G Jacob, Darapiseth Sea, Siratchana Sundrakes, Paktiya Teja-Isavadharm, Nitima Chanarat, Sabaithip Sriwichai, Thay Kheng Heng, You Yom, Char Meng Chuor, Soklyda Chann, Kuntida Tangthongchaiwiriya
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:4631-4643
Cambodia's first-line artemisinin combination therapy, dihydroartemisinin-piperaquine (DHA-PPQ), is no longer sufficiently curative against multidrug-resistant Plasmodium falciparum malaria at some Thai-Cambodian border regions. We report recent (200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471fb67e5d062585f0a609c1a39b679c
https://doi.org/10.1128/aac.00366-15
https://doi.org/10.1128/aac.00366-15
Autor:
Darapiseth Sea, Sok Somethy, Youry Se, Satharath Prom, Chanthap Lon, Worachet Kuntawunginn, Char Meng Chour, David Saunders, Eugene Soh, Douglas B. Tang, Mark C. Haigney, Pattaraporn Vanachayangkul, Sabaithip Sriwichai, Ans Timmermans, Raveewan Siripokasupkul, Jessica E. Manning, Sut-Thang Phann, Soklyda Chann, Jaranit Kaewkungwal, Michele D. Spring, Mashamon Mitprasat, Montida Auayporn, Louis R. Cantilena, Mary So, Nillawan Buathong, Paktiya Teja-Isavadharm, Charlotte A. Lanteri
Publikováno v:
Antimicrobial Agents and Chemotherapy. 58:6056-6067
Dihydroartemisinin-piperaquine, the current first-line drug for uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax in Cambodia, was previously shown to be of benefit as malaria chemoprophylaxis when administered as a monthly 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05e163c98bdc957712d15ea974a3bb1
https://doi.org/10.1128/aac.02667-14
https://doi.org/10.1128/aac.02667-14
Autor:
Jonathan J. Juliano, Charlotte A. Lanteri, Darapiseth Sea, Prom Satharath, Worachet Kuntawunginn, Douglas B. Tang, Jessica E. Manning, Stuart D. Tyner, Douglas S. Walsh, Soklyda Chann, Jaranit Kaewkungwal, Pattaraporn Vanachayangkul, Youry Se, Jessica T. Lin, Panita Gosi, Suwanna Chaorattanakawee, Delia Bethell, David L. Saunders, Chanthap Lon, Michele D. Spring, Mary So, Sabaithip Sriwichai, Char Meng Chuor, Nillawan Buathong, Samon Nou
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e93138 (2014)
PLoS ONE
PLoS ONE
Introduction Emerging antimalarial drug resistance in mobile populations remains a significant public health concern. We compared two regimens of dihydroartemisinin-piperaquine in military and civilians on the Thai-Cambodian border to evaluate nation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::544c902a5ac63798144832d01f9072d6
https://doi.org/10.1371/journal.pone.0093138
https://doi.org/10.1371/journal.pone.0093138